The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Risk of disease recurrence and mortality in gastrointestinal stromal tumor (GIST) patients receiving short-term versus long-term imatinib adjuvant therapy: A chart review analysis.
Anthony Paul Conley
Consultant or Advisory Role - Novartis (U)
Honoraria - Novartis
Annie Guerin
Employment or Leadership Position - Analysis Group
Medha Sasane
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Genevieve Gauthier
Employment or Leadership Position - Analysis Group
Frances Schwiep
Employment or Leadership Position - Analysis Group
Christopher Hunt Keir
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Eric Q. Wu
Employment or Leadership Position - Analysis Group